We are thrilled to publicize the fruitfulconclusion of “Kidney Manthan-2022”.An exclusive 7 days long e-CME Series organized on the occasion of world kidney day 2022 for “Bridging The Knowledge Gap to Better Kidney Care”.
In this enlightening e-CME series 40 eminent speakers from all over India having different background like: Nephrology, MD medicine, Ayurveda, Unani &also from MHFW (Ministry of Health and FamilyWelfare) shared their rich experience &clinical expertise regarding “Multiple Approaches for The Effective Management of Chronic Kidney Diseases”.
We are overwhelmed to share that more than 2500 doctors & healthcare professional registered to attend KIDNEY MANTHAN-2022 on zoom and along with that approximately 4500 people viewed the recorded sessions on social media.
The event was graced by eminent Ayurveda, Allopathy and Unani experts who shared their views and deep knowledge on broad topics like:
Day 1 - Broad Topic: Early Detection and Prevention of Kidney Diseases.
Day 2 - Broad Topic: Clinical Approach for Different Stages of CKD.
Day 3 - Broad Topic: Management of Diabetic/Hypertension/Drug-Induced Nephropathy.
Day 4 - Broad Topic: Supportive Approach for Patients Undergoing Dialysis.
Day 5 - Broad Topic: Improvement in The Quality of Life in Patients of CKD.
Day 6 - Broad Topic: Different Approaches and Clinical Experiences to Manage CKD.
The session was conducted under the expert moderation of Dr Anil Kumar Sharma (Vice President, Aimil Pharmaceuticals Ind. Ltd.) & Dr Mohd. Junaid (MD Ayurveda, Aimil Pharmaceuticals Ind. Ltd.) and at the endevent was concluded with a vote of thanks by Dr. Sanchit Sharma (Executive Director, AIMIL Pharmaceuticals (I) Ltd., Founder Director Ayouthveda, Delhi) and Dr. T.S Easwari (Vice President, Aimil Pharmaceuticals Ind. Ltd.) in which they emphasized that e-CMEs like KIDNEY MANTHAN-2022 should be a regular part of our personal and professional learnings. So that early awareness can be spread among the population to fight the silent pandemic, Chronic Kidney disease.